Featured Content

Adjuvant Lapatinib for HER2+ Breast Cancer

Adjuvant treatment that includes lapatinib did not significantly improve disease-free survival compared with trastuzumab alone.

New Technologies for Patients With Cancer

Researchers and companies are developing mobile technology that offer vetted health care information, reminders, and side-effect trackers to patients and practitioners.

Blood Test Identifies Treatment Resistance in mBC

A new sensitized blood test can help clinicians discover when breast cancers become resistant to standard hormone therapy.

Hospitalization Rates Higher in Survivors of Adolescent Cancer

Those diagnosed with cancer during adolescence or young adulthood are at increased risk for hospitalization compared to those who did not have cancer.

Cost of Cancer Care Addressed at AACR Meeting

Financial stress of cancer care as well as factors that make certain populations more susceptible to certain types of cancers were key points.

Breast Cancer Resources

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs